CN109152806A - 包含杨树芽提取物的组合物及其用途 - Google Patents

包含杨树芽提取物的组合物及其用途 Download PDF

Info

Publication number
CN109152806A
CN109152806A CN201780027904.5A CN201780027904A CN109152806A CN 109152806 A CN109152806 A CN 109152806A CN 201780027904 A CN201780027904 A CN 201780027904A CN 109152806 A CN109152806 A CN 109152806A
Authority
CN
China
Prior art keywords
extract
composition
drying
freeze
weight percent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780027904.5A
Other languages
English (en)
Chinese (zh)
Inventor
瓦伦蒂诺·梅尔卡蒂
路易沙·麦铎力
安娜·麦德赤
安德里亚·卢利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Boka-Agricola Common Shares Co
Original Assignee
A Boka-Agricola Common Shares Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Boka-Agricola Common Shares Co filed Critical A Boka-Agricola Common Shares Co
Priority to CN202511100768.0A priority Critical patent/CN121466191A/zh
Publication of CN109152806A publication Critical patent/CN109152806A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/76Salicaceae (Willow family), e.g. poplar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Vascular Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN201780027904.5A 2016-05-24 2017-05-22 包含杨树芽提取物的组合物及其用途 Pending CN109152806A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202511100768.0A CN121466191A (zh) 2016-05-24 2017-05-22 包含杨树芽提取物的组合物及其用途

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102016000053369 2016-05-24
ITUA2016A003755A ITUA20163755A1 (it) 2016-05-24 2016-05-24 Composizioni a base di gemme di pioppo e loro usi
PCT/IB2017/053000 WO2017203414A1 (en) 2016-05-24 2017-05-22 Compositions comprising extract of poplar buds and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202511100768.0A Division CN121466191A (zh) 2016-05-24 2017-05-22 包含杨树芽提取物的组合物及其用途

Publications (1)

Publication Number Publication Date
CN109152806A true CN109152806A (zh) 2019-01-04

Family

ID=57045271

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201780027904.5A Pending CN109152806A (zh) 2016-05-24 2017-05-22 包含杨树芽提取物的组合物及其用途
CN202511100768.0A Pending CN121466191A (zh) 2016-05-24 2017-05-22 包含杨树芽提取物的组合物及其用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202511100768.0A Pending CN121466191A (zh) 2016-05-24 2017-05-22 包含杨树芽提取物的组合物及其用途

Country Status (11)

Country Link
US (1) US11839638B2 (pl)
EP (1) EP3463409B1 (pl)
JP (1) JP7114486B2 (pl)
CN (2) CN109152806A (pl)
AU (1) AU2017271261B2 (pl)
BR (1) BR112018071958A2 (pl)
EA (1) EA201892349A1 (pl)
ES (1) ES3033734T3 (pl)
IT (1) ITUA20163755A1 (pl)
PL (1) PL3463409T3 (pl)
WO (1) WO2017203414A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUA20163755A1 (it) 2016-05-24 2017-11-24 Aboca Spa Societa Agricola Composizioni a base di gemme di pioppo e loro usi

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000067767A1 (fr) * 1999-05-05 2000-11-16 Pierre Fabre Dermo-Cosmetique Extrait de bourgeons de peuplier et son association avec le squalane comme medicament anti-inflammatoire
WO2011092511A1 (en) * 2010-01-28 2011-08-04 Natures Laboratory Limited Propolis and process for the treatment thereof and end products formed therefrom.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2135201C1 (ru) * 1998-01-20 1999-08-27 Куркин Владимир Александрович Способ получения настойки тополя для лечения гнойно-воспалительных заболеваний мягких тканей
JP3091962B2 (ja) * 1998-09-25 2000-09-25 アルプス薬品工業株式会社 テストステロン−5α−レダクターゼ阻害剤
CN1666753A (zh) * 2004-03-12 2005-09-14 北京大学 一种有抗癌活性的杨属植物芽或芽鳞提取物
JP5414776B2 (ja) * 2004-06-17 2014-02-12 森川健康堂株式会社 プロポリス抽出物の粉末状組成物及びその製造方法
CN105307665B (zh) * 2013-04-05 2021-09-28 蜜纽康新西兰有限公司 治疗性组合物和其用途
CN103315191B (zh) * 2013-07-18 2014-09-03 广南(湛江)家丰饲料有限公司 一种猪用免疫增强剂及其制备方法
ITRM20130592A1 (it) * 2013-10-25 2015-04-26 Aboca Spa Societa Agricola Composizione per la tosse.
ITUA20163755A1 (it) 2016-05-24 2017-11-24 Aboca Spa Societa Agricola Composizioni a base di gemme di pioppo e loro usi

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000067767A1 (fr) * 1999-05-05 2000-11-16 Pierre Fabre Dermo-Cosmetique Extrait de bourgeons de peuplier et son association avec le squalane comme medicament anti-inflammatoire
WO2011092511A1 (en) * 2010-01-28 2011-08-04 Natures Laboratory Limited Propolis and process for the treatment thereof and end products formed therefrom.

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GULHAN: "Composition and in vitro antimicrobial activity of Populus buds and poplar-type propolis", 《WORLD J MICROBIOL BIOTECHNOL》 *
KAI WANG ET AL: "Anti-inflammatory effects of ethanol extracts of Chinese propolis and buds from poplar (Populus canadensis)", 《JOURNAL OF ETHNOPHARMACOLOGY》 *

Also Published As

Publication number Publication date
EP3463409A1 (en) 2019-04-10
ES3033734T3 (en) 2025-08-07
BR112018071958A2 (pt) 2019-02-05
US20200101127A1 (en) 2020-04-02
EA201892349A1 (ru) 2019-04-30
EP3463409B1 (en) 2025-05-07
WO2017203414A1 (en) 2017-11-30
PL3463409T3 (pl) 2025-07-21
CN121466191A (zh) 2026-02-06
AU2017271261B2 (en) 2020-04-09
ITUA20163755A1 (it) 2017-11-24
AU2017271261A1 (en) 2018-10-25
JP2019516740A (ja) 2019-06-20
JP7114486B2 (ja) 2022-08-08
EP3463409C0 (en) 2025-05-07
US11839638B2 (en) 2023-12-12

Similar Documents

Publication Publication Date Title
CN105764519B (zh) 用于治疗咳嗽的基于植物的组合物
US20130045224A1 (en) Immunostimulatory compositions and methods of use thereof
ES2588741T3 (es) Procedimiento para la preparación de composiciones exentas de alcohol sobre una base vegetal, así como composiciones preparadas de este modo y su uso
Chigurupati Antidiabetic and antioxidant potential of Durio zibethinus Murr. leaves ethanolic extract
US20090285921A1 (en) Plant extract and its therapeutic use
CN109152806A (zh) 包含杨树芽提取物的组合物及其用途
CN110300593B (zh) 用于咳嗽的组合物
EP3672589A1 (fr) Produit de combinaison pour soulager les symptômes liés aux infections des voies respiratoires supérieures
EP2817002B1 (de) Kombination aus lipidtransferproteinen und phenolderivate enthaltenden pflanzenstoffen mit lokal-mucosaler effizienz
Akbar et al. Preliminary Phytochemical Analysis, Anthelmintic, Insecticidal and Protective Effect of Dicliptera bupleuroides Nees in Ethanol-induced Gastric Mucosal Damage Rats: Phytochemical and biological activities of Dicliptera bupleuroides Nees
US20150216920A1 (en) Incense extract fractions and uses thereof
KR20190057727A (ko) 기호성이 향상된 기관지 건강 약리 조성물
EA043858B1 (ru) Композиции, содержащие экстракт почек тополя, и способ его получения
Ghavamizadeh et al. The amelioration of gentamycin nephrotoxicity by Cordia myxa L. in rat
D'Souza et al. Primary screening of multipotent therapeutic properties exhibited by Indian propolis
HK40006518B (en) Compositions comprising extract of poplar buds and uses thereof
HK40006518A (en) Compositions comprising extract of poplar buds and uses thereof
Mozaffar Propolis and its effects as a supplement
KR20210002168A (ko) 알긴산 나트륨을 주성분으로 함유한 위건강용 기능성 음료 조성물 및 이의 제조 방법
EP3714940A1 (en) Pharmaceutical formulation for oral use containing honey and plant extracts with an assayed polysaccharide and mucilage content for the treatment of productive and non-productive coughs and throat diseases
DE102004003801A1 (de) Verfahren zur Gewinnung des Stoffes Melanin und Verwendung des Verfahrensproduktes
KR20250040117A (ko) 꼬시래기 추출물을 유효성분으로 하는 호흡기 질환 개선, 예방 또는 치료용 조성물
WO2023057390A1 (fr) Produit de combinaison pour soulager les maux de gorges comprenant du miel, du propolis, de l'erysium et de la mauve
WO2023105429A1 (en) Compositions comprising dimocarpus extract for use in the treatment or prevention of an infection caused by an enveloped virus
Hariharshan Design and in-vitro characterization of metadoxine buccal patches using Borassus flabellifer fruit resin-A novel mucoadhesive polymer

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190104

RJ01 Rejection of invention patent application after publication